thanks for your research on this. Something interesting I picked...

thanks for your research on this. Something interesting I picked up from Abiomed's press release:

• The company announced the acquisition of the remaining interest of preCARDIA for $82.8 million. preCARDIA is the developer of a proprietary catheter and controller that will complement Abiomed’s product portfolio to expand options for upstream heart failure patients acutely decompensating. Annually, more than one million patients are admitted to hospitals in the United States with acute decompensated heart failure (ADHF)¹. Despite available pharmaceutical treatments, heart failure is the leading cause of hospitalization in patients older than 65 years of age². preCARDIA will provide heart failure specialists a minimally invasive solution with the potential to improve patient outcomes and lower the cost of care by providing early intervention with this new technology.

Could Sensera be becoming a takeover target?